FDA

Standard Homeopathic recalls Hyland’s teething tablets

Standard Homeopathic recalls Hyland’s teething tablets

Los Angeles-based Standard Homeopathic Co. has issued a nationwide recall for any remaining packages of its teething tablets after regulators warned that the medicine has inconsistent levels of an herb that might be poisonous.

Standard Homeopathic stopped producing and supplying Hyland’s teething tablets in October last year, and notified distributors as well as stores to return the tablets. Consumers who might have already purchased the tablets were advised to throw them out.

News: 
Location: 
Company: 

FDA approves 23andMe’s genetic testing kit

FDA approves 23andMe’s genetic testing kit

The U.S. Food & Drug Administration (FDA) has finally approved 23andMe’s personal genetic test for certain diseases, including Parkinson’s, Alzheimer’s, and celiac diseases.

The FDA said in statement that the genetic test assess genetic risk for the aforementioned conditions but does not diagnose them. The federal agency also urged people to use their results to help make decisions regarding lifestyle choices and to inform discussions with a healthcare expert.

News: 
Location: 
Company: 

FDA investigating Vulto cheese-linked listeria outbreak

FDA investigating Vulto cheese-linked listeria outbreak

The U. S. Food & Drug Administration (FDA) has confirmed that it has launched an investigation into the most recent multistate outbreak of listeriosis that has been linked to soft raw milk cheese produced by Vulto Creamery.

Vulto Creamery recalled its Heinennellie, Willowemoc, Miranda and Ouleout raw milk cheeses on Tuesday, after at least two deaths and half a dozen hospitalizations were linked to the products. Walton Umber, Andes, Blue Blais and Hamden cheeses are also being recalled.

News: 
Location: 
Company: 

EMA gives conditional approval to AbbVie’s cancer drug

EMA gives conditional approval to AbbVie’s cancer drug

An advisory committee of the European Medicines Agency (EMA) on Friday gave its conditional backing to AbbVie Inc.’s venclyxto, a drug developed to treat a form of blood cancer.

News: 
Location: 
Company: 

FDA reaffirms anticoagulant drug rivaroxaban’s safety and efficacy

FDA reaffirms anticoagulant drug rivaroxaban’s safety and efficacy

Following an extended trial and uncertainty, the U.S. Food & Drug Administration (FDA) on Tuesday reaffirmed the anticoagulant drug rivaroxaban’s safety and efficacy.

News: 
Location: 
Company: 

Hepatitis C can reactivate dormant hepatitis B virus: FDA

Hepatitis C can reactivate dormant hepatitis B virus: FDA

A seemingly miraculous class of drugs that are used to cure hepatitis C can cause a reactivation of dormant hepatitis B virus in some patients and subsequently lead them to death, the Food & Drug Administration (FDA) has warned.

The federal agency announced on Wednesday that it would require pharmaceutical firms that produce certain direct-acting antiviral (DAA) medicines to put a black box label onto their products to warn patients that the products can reactivate the hepatitis B virus in patients infected with both.

Company: 

Philips unveils new health platform and products to empower people to take greater control of health

Philips unveils new health platform and products to empower people to take great

On Monday, Philips came up with a new health platform and ecosystem of products to enable people to take greater control of their health. The target of the Dutch healthcare company isn't the fitness buffs, but the normal people vulnerable to chronic diseases, including high blood pressure, high cholesterol, and heart disease.

Location: 
Company: 

Antiretroviral drugs can alone significantly lower risk of HIV transmission

Antiretroviral drugs can alone significantly lower risk of HIV transmission

A new study found that a drug alone can prevent spread of HIV among gay men. The antiretroviral drugs (ARVs) have been shown to reduce the risk of contracting HIV by up to 96% from HIV positive partner. The FDA approved the drug in 2012 which became first drug to prevent HIV transmission.

Location: 
Company: 

FDA to Test Glyphosate Residues in Food for First Time This Year

FDA to Test Glyphosate Residues in Food for First Time This Year

Two years back, US Government Accountability Office (GAO) criticized US Food and Drug Administration (FDA) for lack of monitoring the presence of glyphosate residues in food. The agency has now come up with a method capable of testing residue of glyphosate, one of the most widely used herbicide globally, produced under trade name Roundup by the agrochemical corporation Monsanto.

Company: 

Medical-grade wearables might soon be available in the market

Medical-grade wearables might soon be available in the market

Experts from the healthcare industry have said that a number of wearable computing devices that help detect and monitor serious diseases are ready to enter the market.

News: 
Location: 
Company: 

Pages

Popular Stories

China’s export-import growth slips

China suffered a minor setback in the growth of its... Read More

Renault signs new JV in Iran

French carmaker Renault has confirmed that it has... Read More

Activist Investor Ackman wants five ADP board seats

After acquiring an 8 per cent stake in Automatic... Read More

Yoga can efficiently ease depression: Research

Yoga can not only efficiently help relax your body... Read More

Facebook preparing to demote slow-loading stories on News Feed

Facebook, the world’s largest social network, is... Read More

Facebook reportedly working on dedicated video chat device

Social-networking giant Facebook is reportedly... Read More